Results 11 to 20 of about 233,223 (318)
Kidney International Reports, 2020 Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes).
Keiichi Sumida +2 more
openaire +3 more sources
Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study [PDF]
Kidney360, 2022 Key Points The CKD-PGX study assessed the feasibility of pharmacogenomic testing for a panel of antihypertensive agent efficacy predictors.
Michael T. Eadon +11 more
openaire +2 more sources
Slowing Progression in CKD [PDF]
Clinical Journal of the American Society of Nephrology, 2021 There is a recognized large global burden of CKD ([1][1]). With the projected rise in prevalence of diabetes in coming years, that burden may indeed increase. Thus, the need for therapies to slow the progression of CKD, and its attendant comorbidities, is critical.
Kathryn, Larmour, Adeera, Levin
openaire +2 more sources
Phosphate, Microbiota and CKD [PDF]
Nutrients, 2021 Phosphate is a key uremic toxin associated with adverse outcomes. As chronic kidney disease (CKD) progresses, the kidney capacity to excrete excess dietary phosphate decreases, triggering compensatory endocrine responses that drive CKD-mineral and bone disorder (CKD-MBD).
Chiara Favero +8 more
openaire +4 more sources
Nephrology Dialysis Transplantation, 2014 International ...
J. Fernandes +125 more
openaire +3 more sources
Clinical Journal of the American Society of Nephrology, 2019 In general, nephrologists give little thought to contraception, leaving this task to other practitioners, but the significant risks associated with drugs routinely prescribed to treat kidney disease; the potential for pregnancy-associated adverse outcomes in women with CKD; and the effect ...
Anna, Burgner, Michelle A, Hladunewich
openaire +2 more sources
Mechanisms and Treatment of CKD [PDF]
Journal of the American Society of Nephrology, 2012 As CKD continues to increase worldwide, along with the demand for related life-saving therapies, the financial burden of CKD will place an increasing drain on health care systems. Experimental studies showed that glomerular capillary hypertension and impaired sieving function with consequent protein overload play a pathogenic role in the progression of
P. Ruggenenti, P. Cravedi, G. Remuzzi
openaire +3 more sources
CKD in Disadvantaged Populations [PDF]
Canadian Journal of Kidney Health and Disease, 2014 The increased burden of CKD in disadvantaged populations is due to both global factors and population-specific issues. Low socioeconomic status and poor access to care contribute to healthcare disparities and exacerbate the negative effects of genetic or biologic predisposition.
Guillermo Garcia-Garcia, Vivekanand Jha
openaire +19 more sources
Masked CKD in hyperthyroidism and reversible CKD status in hypothyroidism
Frontiers in Endocrinology, 2022 IntroductionWhile it is well known that thyroid function may affect kidney function, the transition of the chronic kidney disease (CKD) status before and after treatment for thyroid disorders, as well as the factors affecting this change, remains to be explored.
Uchiyama-Matsuoka, Natsumi +12 more
openaire +4 more sources
Bioavailability of the Common Cold Medicines in Jellies for Oral Administration
Pharmaceutics, 2020 Jellies for oral administration have been suggested as alternative dosage forms to conventional tablets for improved palatability and compliances for pediatric and geriatric patients.
Ki Hyun Kim, Minju Jun, Mi-Kyung Lee
doaj +1 more source